Zhejiang Jiuzhou Pharmaceutical (SHA:603456) subsidiary Jiuzhou Biopharmaceutical (Taizhou) received a drug registration certificate from China's National Medical Products Administration for its tandospirone citrate tablets, according to a Friday filing with the Shanghai bourse.
Tandospirone citrate is indicated for anxiety, including those accompanying physical diseases such as essential hypertension and peptic ulcers, the filing said.
Sumitomo Pharmaceutical first developed the drug in 1996.